PVP

PVP Ventures Limited

Holding company for real estate and healthcare businesses

Consumer Discretionary›Realty›Realty›Residential, Commercial Projects

pvpglobal.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹44.17
Market cap
1,150 Cr
Stock P/E
230.3
P/B
5.27
ROE (FY26)
-1.7%
ROCE (FY26)
3.9%
Operating margin (FY26)
5.4%
Debt / equity (FY26)
1.08
OCF / EBITDA (FY26)
-130.5%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

PVP Ventures is building a healthcare services business through acquisitions while collecting cash from the development of a legacy real-estate land bank.

Company snapshot

40thBy market cap

Ranked among 79 companies in Residential, Commercial Projects.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 110.5% of revenue

SegmentRevenue shareRevenuePBTAssets
HEALTHCARE
101.6%
3 Cr-0.62 Cr45 Cr
MOVIE RELATED—0 Cr0 Cr0 Cr
REAL ESTATE
110.5%
3 Cr-1 Cr339 Cr

Shares add up to 212% because segment revenues are before inter-segment eliminations.

What we see

Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales0.03 Cr4 Cr4 Cr3 Cr3 Cr2 Cr19 Cr17 Cr17 Cr14 Cr41 Cr46 Cr
Operating expenses (approx.)3 Cr7 Cr7 Cr6 Cr8 Cr7 Cr14 Cr12 Cr15 Cr9 Cr34 Cr32 Cr
EBITDA-3 Cr-3 Cr-3 Cr-4 Cr-5 Cr-4 Cr5 Cr5 Cr2 Cr5 Cr7 Cr13 Cr
OPM %-10877.0%-59.0%-87.5%-143.7%-154.1%-171.9%27.4%29.3%14.0%35.8%17.4%29.1%
Other income0.07 Cr0.87 Cr7 Cr3 Cr3 Cr3 Cr3 Cr4 Cr4 Cr3 Cr12 Cr26 Cr
Interest0.66 Cr3 Cr0.85 Cr1 Cr1 Cr0.49 Cr0.86 Cr8 Cr8 Cr8 Cr9 Cr10 Cr
Depreciation0.22 Cr0.71 Cr0.75 Cr0.60 Cr0.61 Cr0.59 Cr0.24 Cr1 Cr1 Cr1 Cr10 Cr6 Cr
Profit before tax-4 Cr67 Cr2 Cr-3 Cr-4 Cr-3 Cr0.18 Cr-0.50 Cr-4 Cr-2 Cr-2 Cr12 Cr
Tax %0.0%0.0%-177.6%16.8%20.0%71.3%1510.2%77.0%27.3%-119.1%-27.9%7.8%
Net profit-4 Cr67 Cr7 Cr-2 Cr-3 Cr-0.74 Cr-3 Cr-0.11 Cr-3 Cr-4 Cr-3 Cr11 Cr
EPS (₹)₹-0.17₹2.59₹0.26₹-0.09₹-0.10₹-0.02₹-0.06₹0.01₹-0.12₹-0.14—₹0.46

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales156 Cr58 Cr37 Cr44 Cr18 Cr49 Cr176 Cr8 Cr27 Cr90 CrSign in free for the trailing twelve months
Operating expenses (approx.)111 Cr68 Cr81 Cr64 Cr31 Cr42 Cr46 Cr20 Cr35 Cr71 CrSign in free for the trailing twelve months
EBITDA45 Cr-9 Cr-44 Cr-21 Cr-14 Cr7 Cr129 Cr-12 Cr-8 Cr19 CrSign in free for the trailing twelve months
OPM %28.7%-15.5%-120.0%-47.5%-75.9%14.8%73.7%-139.6%-27.8%20.7%Sign in free for the trailing twelve months
Other income1 Cr0.51 Cr0.46 Cr0.80 Cr2 Cr0.76 Cr0.40 Cr8 Cr11 Cr23 CrSign in free for the trailing twelve months
Interest47 Cr51 Cr59 Cr69 Cr61 Cr68 Cr10 Cr5 Cr4 Cr34 CrSign in free for the trailing twelve months
Depreciation1 Cr1 Cr2 Cr2 Cr2 Cr0.87 Cr1 Cr2 Cr2 Cr14 CrSign in free for the trailing twelve months
Profit before tax-2 Cr-60 Cr-116 Cr-91 Cr-81 Cr-95 Cr263 Cr62 Cr-9 Cr-8 CrSign in free for the trailing twelve months
Tax %619.5%-2.6%-0.0%-3.0%0.0%-0.0%9.4%-7.1%3.3%-18.3%Sign in free for the trailing twelve months
Net profit8 Cr-62 Cr-116 Cr-93 Cr-81 Cr-95 Cr238 Cr66 Cr-9 Cr-10 CrSign in free for the trailing twelve months
EPS (₹)₹0.34₹-2.54₹-4.77₹-3.83₹-3.29₹-3.89₹9.75₹2.60₹-0.26₹-0.25Sign in free for the trailing twelve months
Dividend payout %——————0.0%0.0%——Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital244 Cr244 Cr244 Cr244 Cr244 Cr244 Cr244 Cr260 Cr260 Cr260 Cr
Reserves5 Cr-32 Cr-114 Cr-176 Cr-233 Cr-292 Cr-96 Cr-31 Cr-37 Cr145 Cr
Borrowings301 Cr304 Cr348 Cr293 Cr265 Cr371 Cr182 Cr41 Cr22 Cr237 Cr
Other liabilities190 Cr201 Cr231 Cr322 Cr386 Cr314 Cr49 Cr109 Cr132 Cr152 Cr
Total liabilities776 Cr728 Cr669 Cr611 Cr566 Cr505 Cr339 Cr379 Cr376 Cr794 Cr
Fixed assets (net)4 Cr13 Cr12 Cr14 Cr5 Cr4 Cr2 Cr5 Cr6 Cr102 Cr
CWIP9 Cr———0 Cr0 Cr—0 Cr0 Cr0.32 Cr
Investments52 Cr44 Cr33 Cr29 Cr18 Cr14 Cr0 Cr8 Cr2 Cr6 Cr
Loans & advances———56 Cr41 Cr18 Cr1 Cr0.08 Cr0.14 Cr4 Cr
Inventories338 Cr333 Cr344 Cr341 Cr341 Cr327 Cr306 Cr52 Cr51 Cr54 Cr
Trade receivables23 Cr13 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr1 Cr26 Cr
Cash & bank6 Cr1 Cr2 Cr0.0020 Cr4 Cr0.33 Cr2 Cr0.76 Cr0.61 Cr51 Cr
Other assets344 Cr323 Cr277 Cr169 Cr156 Cr140 Cr25 Cr312 Cr315 Cr550 Cr
Total assets776 Cr728 Cr669 Cr611 Cr566 Cr505 Cr339 Cr379 Cr376 Cr794 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity48 Cr-8 Cr-13 Cr17 Cr6 Cr-22 Cr327 Cr0.49 Cr20 Cr-24 Cr
Cash from investing19 Cr7 Cr19 Cr2 Cr7 Cr1 Cr210 Cr6 Cr3 Cr-153 Cr
Cash from financing-63 Cr-4 Cr-6 Cr-21 Cr-10 Cr17 Cr-116 Cr-8 Cr-23 Cr190 Cr
Net cash flow5 Cr-5 Cr0.50 Cr-1 Cr4 Cr-4 Cr421 Cr-1 Cr-0.15 Cr13 Cr
Free cash flow (OCF − Capex)41 Cr-10 Cr-14 Cr17 Cr6 Cr-22 Cr325 Cr-2 Cr19 Cr-87 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %7.8%-1.8%-13.0%-8.0%-8.6%3.3%94.1%24.8%-2.0%3.9%
ROE %2.9%-27.9%-73.7%———219.8%29.0%-3.0%-1.7%
Debtor days53791613331347718106
Inventory days7927242339812610409130011219557414988120171375
Days payable1596187918568742417541272585
Cash conversion cycle830722533961254340727651115855541331110763895
OCF / EBITDA %108.4%————-305.0%252.9%——-130.5%
OCF / EBITDA % (3 years)——————253.0%244.9%316.3%—
Debt / equity1.211.433.83———1.680.180.101.08
Current ratio2.242.041.581.080.870.663.321.321.351.14
Net debt / EBITDA6.62————51.221.39——10.00